Novavax says COVID vaccine triggers immune response to Omicron variant
Carl O'Donnell, Reuters
Updated as of Dec 23 03:07 PM
Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant. Read more »